BMY vs PLUS · P/E 17, rev $48.19B vs P/E 17, rev $2.07B
Bristol-Myers Squibb Company (BMY) versus ePlus inc (PLUS) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Not investment advice. Open the BMY and PLUS stock pages for the full models.
Not investment advice.